3-aminobenzamide has been researched along with Hypertension in 1 studies
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waldman, M | 1 |
| Nudelman, V | 1 |
| Shainberg, A | 1 |
| Abraham, NG | 1 |
| Kornwoski, R | 1 |
| Aravot, D | 1 |
| Arad, M | 1 |
| Hochhauser, E | 1 |
1 other study available for 3-aminobenzamide and Hypertension
| Article | Year |
|---|---|
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axis.
Topics: Animals; Cells, Cultured; Diabetic Cardiomyopathies; Enzyme Inhibitors; Glucose; Heart; Hypertension | 2018 |